feed,title,long_url,short_url
MarketWatch,Biogen says its Alzheimer's treatment Aducanumab got a 'negative trend vote' from EU regulator,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=BIIB&siteid=rss,https://on.mktw.net/30CWhll
